Latest Regulatory News

Santos Limited's 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet highlights significant progress in carbon capture and storage and emissions reduction efforts.

Santos Limited’s 2024 Annual Report reveals a 5% drop in production and a 9% decline in sales revenue, yet the company delivered a solid $1.224 billion net profit while making significant strides in carbon capture and storage and emissions reduction.

Santos Limited’s 2024 Annual Report reveals a 5% drop in production and a 9% fall in sales revenue, yet the company maintains strong profitability and advances its carbon capture and storage projects alongside ambitious climate goals.

Santos Limited’s 2024 Annual Report reveals a 5% decline in production and a 9% drop in sales revenue, yet the company progresses its climate ambitions with the successful start-up of the Moomba CCS project and robust emissions reductions.

Jameson Resources has made significant strides in advancing its Crown Mountain Hard Coking Coal Project in British Columbia, leveraging strong government engagement and Indigenous partnerships to expedite environmental approvals.

Native Mineral Resources Holdings Limited (NMR) has made significant progress on its Charters Towers Gold Project, completing key plant refurbishments and securing $15.9 million in funding to support a planned gold production restart in Q3 2025.

Westgold Resources reported robust Q3 FY25 exploration results, drilling 83km and investing $11 million across its Murchison and Southern Goldfields portfolios, highlighting high-grade gold intercepts and advancing the Fortnum Expansion Project.

Icon Energy Limited has received a Notice of Proposed Grant for Petroleum Lease PL-1144 in the Cooper Basin, marking a significant step toward resource development. Meanwhile, the company secured a $300,000 unsecured loan under revised terms, though its shares remain suspended pending native title negotiations and ASX approval.

Traka Resources has made a strategic leap into West Africa with a joint venture on the Didi Gold Project in Guinea, positioning itself near AngloGold Ashanti’s prolific Siguiri Mine. The company plans targeted drilling next quarter while maintaining its Australian exploration assets.

Island Pharmaceuticals has completed dosing in the Phase 2b cohort of its dengue fever trial, with pharmacokinetic targets met and top-line results expected next month. The company also strengthened its balance sheet by raising $1.94 million through option exercises.

Santos Limited’s 2024 Annual Report reveals a 5% drop in production and a 9% revenue decline, offset by progress in carbon capture and storage projects and emissions reductions. The company maintains a strong balance sheet while setting ambitious climate targets.

Amplia Therapeutics has completed recruitment early for its Phase 2a ACCENT trial in advanced pancreatic cancer, reporting encouraging interim results and advancing a second trial with FDA-backed protocol changes.